181 related articles for article (PubMed ID: 38464227)
1. Metabolic control of adaptive β-cell proliferation by the protein deacetylase SIRT2.
Wortham M; Ramms B; Zeng C; Benthuysen JR; Sai S; Pollow DP; Liu F; Schlichting M; Harrington AR; Liu B; Prakash TP; Pirie EC; Zhu H; Baghdasarian S; Auwerx J; Shirihai OS; Sander M
bioRxiv; 2024 Feb; ():. PubMed ID: 38464227
[TBL] [Abstract][Full Text] [Related]
2. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming.
Xu L; Wang L; Zhou L; Dorfman RG; Pan Y; Tang D; Wang Y; Yin Y; Jiang C; Zou X; Wu J; Zhang M
Neoplasia; 2019 May; 21(5):429-441. PubMed ID: 30933885
[TBL] [Abstract][Full Text] [Related]
3. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
4. SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux.
Zhou F; Zhang L; Zhu K; Bai M; Zhang Y; Zhu Q; Wang S; Sheng C; Yuan M; Liu Y; Lu J; Shao L; Wang X; Zhou L
Theranostics; 2021; 11(10):4825-4838. PubMed ID: 33754030
[No Abstract] [Full Text] [Related]
5. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.
North BJ; Marshall BL; Borra MT; Denu JM; Verdin E
Mol Cell; 2003 Feb; 11(2):437-44. PubMed ID: 12620231
[TBL] [Abstract][Full Text] [Related]
6. Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy.
Liu G; Park SH; Imbesi M; Nathan WJ; Zou X; Zhu Y; Jiang H; Parisiadou L; Gius D
Antioxid Redox Signal; 2017 May; 26(15):849-863. PubMed ID: 27460777
[TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus.
Yoo DY; Kim DW; Kim MJ; Choi JH; Jung HY; Nam SM; Kim JW; Yoon YS; Choi SY; Hwang IK
Neurol Res; 2015 Jan; 37(1):69-76. PubMed ID: 24963697
[TBL] [Abstract][Full Text] [Related]
8. SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation.
Li C; Zhou Y; Rychahou P; Weiss HL; Lee EY; Perry CL; Barrett TA; Wang Q; Evers BM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):43-57. PubMed ID: 31954883
[TBL] [Abstract][Full Text] [Related]
9. The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer.
Zhou W; Ni TK; Wronski A; Glass B; Skibinski A; Beck A; Kuperwasser C
Cell Rep; 2016 Oct; 17(5):1302-1317. PubMed ID: 27783945
[TBL] [Abstract][Full Text] [Related]
10. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.
Wang F; Nguyen M; Qin FX; Tong Q
Aging Cell; 2007 Aug; 6(4):505-14. PubMed ID: 17521387
[TBL] [Abstract][Full Text] [Related]
11. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
[TBL] [Abstract][Full Text] [Related]
12. Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.
Hamaidi I; Zhang L; Kim N; Wang MH; Iclozan C; Fang B; Liu M; Koomen JM; Berglund AE; Yoder SJ; Yao J; Engelman RW; Creelan BC; Conejo-Garcia JR; Antonia SJ; Mulé JJ; Kim S
Cell Metab; 2020 Sep; 32(3):420-436.e12. PubMed ID: 32768387
[TBL] [Abstract][Full Text] [Related]
13. SIRT2 deacetylates GRASP55 to facilitate post-mitotic Golgi assembly.
Zhang X; Brachner A; Kukolj E; Slade D; Wang Y
J Cell Sci; 2019 Nov; 132(21):. PubMed ID: 31604796
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the NAD-dependent protein deacetylase SIRT2 induces granulocytic differentiation in human leukemia cells.
Sunami Y; Araki M; Hironaka Y; Morishita S; Kobayashi M; Liew EL; Edahiro Y; Tsutsui M; Ohsaka A; Komatsu N
PLoS One; 2013; 8(2):e57633. PubMed ID: 23460888
[TBL] [Abstract][Full Text] [Related]
15. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B
Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652
[TBL] [Abstract][Full Text] [Related]
16. SIRT2 interacts with β-catenin to inhibit Wnt signaling output in response to radiation-induced stress.
Nguyen P; Lee S; Lorang-Leins D; Trepel J; Smart DK
Mol Cancer Res; 2014 Sep; 12(9):1244-53. PubMed ID: 24866770
[TBL] [Abstract][Full Text] [Related]
17. SIRT2 negatively regulates insulin resistance in C2C12 skeletal muscle cells.
Arora A; Dey CS
Biochim Biophys Acta; 2014 Sep; 1842(9):1372-8. PubMed ID: 24793418
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.
Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572
[TBL] [Abstract][Full Text] [Related]
19. The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes.
Lemos V; de Oliveira RM; Naia L; Szegö É; Ramos E; Pinho S; Magro F; Cavadas C; Rego AC; Costa V; Outeiro TF; Gomes P
Hum Mol Genet; 2017 Nov; 26(21):4105-4117. PubMed ID: 28973648
[TBL] [Abstract][Full Text] [Related]
20. RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model.
Wang Y; Yang JQ; Hong TT; Sun YH; Huang HL; Chen F; Chen XJ; Chen HY; Dong SS; Cui LL; Yang TL
Aging Cell; 2020 Aug; 19(8):e13194. PubMed ID: 32700357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]